Your browser doesn't support javascript.
loading
Immunohistochemical, genetic and epigenetic profiles of hereditary and triple negative breast cancers. Relevance in personalized medicine.
Murria, Rosa; Palanca, Sarai; de Juan, Inmaculada; Alenda, Cristina; Egoavil, Cecilia; Seguí, Francisco J; García-Casado, Zaida; Juan, María J; Sánchez, Ana B; Segura, Ángel; Santaballa, Ana; Chirivella, Isabel; Llop, Marta; Pérez, Gema; Barragán, Eva; Salas, Dolores; Bolufer, Pascual.
Affiliation
  • Murria R; Laboratory of Molecular Biology, Service of Clinical Analysis, University Hospital La Fe Valencia, Spain.
  • Palanca S; Laboratory of Molecular Biology, Service of Clinical Analysis, University Hospital La Fe Valencia, Spain.
  • de Juan I; Laboratory of Molecular Biology, Service of Clinical Analysis, University Hospital La Fe Valencia, Spain.
  • Alenda C; Department of Pathology, University General Hospital Alicante, Spain.
  • Egoavil C; Department of Pathology, University General Hospital Alicante, Spain.
  • Seguí FJ; Department of Pathology, University General Hospital Alicante, Spain.
  • García-Casado Z; Laboratory of Molecular Biology, IVO Valencia, Spain.
  • Juan MJ; Department of oncology, IVO Valencia, Spain.
  • Sánchez AB; Genetic Counseling Unit, Elche Hospital Alicante, Spain.
  • Segura Á; Genetic Counseling Unit, University Hospital La Fe Valencia, Spain.
  • Santaballa A; Department of oncology, University Hospital La Fe Valencia, Spain.
  • Chirivella I; Genetic Counseling Unit, Clinic University Hospital Valencia, Spain.
  • Llop M; Laboratory of Molecular Biology, Service of Clinical Analysis, University Hospital La Fe Valencia, Spain.
  • Pérez G; Laboratory of Molecular Biology, Service of Clinical Analysis, University Hospital La Fe Valencia, Spain.
  • Barragán E; Laboratory of Molecular Biology, Service of Clinical Analysis, University Hospital La Fe Valencia, Spain.
  • Salas D; General Department of Public Health, Conselleria de Sanitat Generalitat Valenciana, Spain.
  • Bolufer P; Laboratory of Molecular Biology, Service of Clinical Analysis, University Hospital La Fe Valencia, Spain.
Am J Cancer Res ; 5(7): 2330-43, 2015.
Article in En | MEDLINE | ID: mdl-26328265

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Am J Cancer Res Year: 2015 Document type: Article Affiliation country: España Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Am J Cancer Res Year: 2015 Document type: Article Affiliation country: España Country of publication: Estados Unidos